TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

BYRYZN

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

BYRYZN

ST13

US500000079347334

Classe

3, 5, 10

Pedido

79347334

Registro

7292313

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

29

Atualização mais recente

08/05/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

3, 5, 10

Data de depósito

27/04/2022

Data de registro

30/01/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

30/01/2024

Última transação

08/05/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

03

Localização do titular

KR

Examinador

BULLOFF, TOBY

Unidade examinadora

N10

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

HUGEL INC.

Representantes

Diane J. Mason Faegre Drinker Biddle & Reath LLP

Classificação técnica

Classes Nice

Classe 3Classe 5Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 3

Cosmetics; functional cosmetics being non-medicated skin care preparations; anti-aging cosmetic preparations; cosmetic preparations for skin renewal; cosmetic preparations for skin care; wrinkle-minimizing cosmetic preparations for topical facial use; non-medicated skin ointment; anti-wrinkle creams; wrinkle removing skin care preparations; age retardant gels for cosmetic use; mask pack for cosmetic purposes; pores tightening mask packs used as cosmetics; essential oils; lotions for face and body care; toilet water; Make-up bases, namely, Make-up primer and Make-up foundation; whitening essences for skincare; sun block; cosmetics for face washes; cosmetic lip care creams

Classe 5

Injectable dermal fillers; hyaluronic acid mixed with its derivatives and other polysaccharides, including or not including lidocaine, in ampoule form for medical purposes; hyaluronic acid preparations for medical purposes; pharmaceutical preparations mainly based on hyaluronic acid for improving skin tone and texture; hyaluronic acid preparations for medical purposes in the form of prefilled injectable pharmaceuticals; pre-filled syringes for medical purposes containing saline for rehydrating the skin, pharmaceuticals for dissolving skin wrinkles; filled syringes for medical purposes containing pharmaceuticals for rehydrating the skin, dissolving skin wrinkles; drugs for medical purposes for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis and cerebral palsy; drugs for medical purposes for the treatment of sports injuries, namely, injured or torn skin, muscle, ligaments or bone; drugs for medical purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmacological preparations for skin care; tissue-regenerative pharmaceutical preparations; dermatological pharmaceutical products; pharmaceutical preparations for the treatment of wrinkles; medicated skin care preparations; tissues impregnated with pharmaceutical lotions for skin conditions, sunburn; medicated ointments for treating dermatological conditions; medicated lotions and creams for the body, skin, face, and hands; pharmacological preparations for cosmetic treatment, namely, medicated cosmetics; medicated skin lotions; modified hyaluronic acid preparations for medical purposes; medical topical gels for activation of skin tissues; medicines for treating dermatological conditions; filler for urological purposes being injectable dermal fillers; self injection syringes for medical purposes for injection of prefilled hyaluronic acid; pharmacological preparations for cosmetic surgery, namely, anesthetics for surgery, medicated ointment for treating dermatological conditions; filler for plastic surgery being injectable dermal fillers; biological biomaterials for tissue restoration for medical purposes; filler for dermatology being injectable dermal fillers; implants comprising living tissue; skin grafts

Classe 10

Medical apparatus for injecting fillers; bone void fillers comprised of artificial materials; filler injectors for medical purposes; injection device for pharmaceuticals; syringes for medical purposes; disposable hypodermic syringes for medical use; hypodermic syringes for use in administering injection substances; syringes for injections; medical apparatus and instruments for the treatment of skin; medical apparatus and instruments for plastic surgery; artificial implants for skin regeneration; artificial skin for surgical purposes; medical skin enhancement apparatus using lasers; medical esthetic machine for skin massage; medical apparatus for skin wrinkle removal; medical apparatus and instruments for urological purposes; medical apparatus which includes a syringe for introducing pharmaceutical preparations into the human body; artificial implants for medical, surgical, urological, dermatological and plastic surgery; Medical instruments, namely, surgical thread; Medical instruments, namely, laser instruments for medical use; Medical apparatus and instruments, namely, surgical apparatus and instruments; medical bone prostheses; electric injection apparatus which includes a filler injector for medical purposes; dermic implants including visco-supplementation substances for medical use, intended for wrinkle filling or volume increasing, namely, artificial skin for surgical use; Medical apparatus, namely, lasers for the cosmetic treatment of the face and skin; Medical apparatus, namely, electronic light therapy apparatus for the skin; medical apparatus and instruments for dermatological use; syringes for injection of medical substances for the skin used for injection of a hyaluronic acid gel in a pre-filled syringe for reducing wrinkles, filling scars and contouring the lips and face

Publicações

Histórico de despachos e eventos da marca no USPTO.

29 publicações encontradas

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

11/04/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

27/05/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/05/2024

FIMP

FINAL DISPOSITION PROCESSED

02/05/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

30/04/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/02/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

30/01/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

30/01/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

17/01/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

17/01/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

14/11/2023

PUBO

PUBLISHED FOR OPPOSITION

14/11/2023

GPNX

NOTIFICATION PROCESSED BY IB

13/11/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

25/10/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

25/10/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/10/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/10/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/10/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/10/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/10/2023

RFNT

REFUSAL PROCESSED BY IB

25/04/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/04/2023

RFRR

REFUSAL PROCESSED BY MPU

05/04/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

17/02/2023

CNRT

NON-FINAL ACTION WRITTEN

16/02/2023

DOCK

ASSIGNED TO EXAMINER

15/02/2023

MAFR

APPLICATION FILING RECEIPT MAILED

16/08/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/08/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/08/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace BYRYZN ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.